Transferable R factors in enteric bacteria causing infection of the genitourinary tract.

PubWeight™: 5.01‹?› | Rank: Top 1%

🔗 View Article (PMID 4161048)

Published in Lancet on July 02, 1966

Authors

D H Smith, S E Armour

Articles citing this

Phylogenetic relationships of drug-resistance factors and other transmissible bacterial plasmids. Bacteriol Rev (1968) 9.19

Host range and properties of the Pseudomonas aeruginosa R factor R1822. J Bacteriol (1973) 8.80

Genetics of Pseudomonas. Bacteriol Rev (1969) 6.91

Thermosensitive replication of a kanamycin resistance factor. J Bacteriol (1967) 4.46

Transferable drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1972) 2.83

Genetic transfer and bacterial taxonomy. Bacteriol Rev (1970) 2.10

Resistant urinary infections resulting from changes in resistance pattern of faecal flora induced by sulphonamide and hospital environment. Br Med J (1970) 1.81

Further studies on the antibiotic resistance of Shigella sonnei. I. Transferable antibiotic resistance. J Hyg (Lond) (1968) 1.78

Frequency of R factor-mediated multiple drug resistance in Klebsiella and Aerobacter. Appl Microbiol (1969) 1.55

Drug resistance of enteric bacteria. IX. Distribution of R factors in gram-negative bacteria from clinical sources. J Bacteriol (1967) 1.47

Antibiotic resistance and survival of E coli in the alimentary tract. Br Med J (1975) 1.45

Infectious drug resistance among clinically isolated Escherichia coli. J Bacteriol (1968) 1.45

Drug resistance of enteric bacteria. 13. Distribution of R factors in Escherichia coli strains isolated from livestock. J Bacteriol (1967) 1.29

Drug resistance of staphylococci. VI. Genetic determinant for chloramphenicol resistance. J Bacteriol (1968) 1.11

The influence of bacteriocins on resistance to infection by gram-negative bacteria. II. Colicin action, transfer of colicinogeny, and transfer of antibiotic resistance in urinary infections. J Clin Invest (1968) 1.04

Transferable drug resistance among Enterobacteriaceae isolated from human urinary tract infections. Appl Microbiol (1969) 1.04

Differentiation between vibrio cholerae and Vibrio cholerae biotype El Tor by the polymyxin B disc test: comparative results with TCBS, Monsur's, Mueller-Hinton and nutrient agar media. Bull World Health Organ (1967) 1.02

Multiresistant plasmids from Pseudomonas aeruginosa highly resistant to either or both gentamicin and carbenicillin. Antimicrob Agents Chemother (1976) 1.02

Characterization of an ampicillin-resistant Haemophilus influenzae type B. Antimicrob Agents Chemother (1976) 0.99

Survey of infectious multiple drug resistance among salmonella isolated from animals in the United States. Appl Microbiol (1971) 0.98

Typhoid fever imported from Mexico to Switzerland. Studies on R factor mediated chloramphenicol resistance. J Hyg (Lond) (1973) 0.91

Transferable antibiotic resistance in enteropathogenic Escherichia coli between 1948 and 1968. Antimicrob Agents Chemother (1973) 0.88

Transferable drug resistance among Enterobacteriaceae isolated from cases of neonatal diarrhea in calves and piglets. Appl Microbiol (1969) 0.86

The effect of chlortetracycline feed additive on the antibiotic resistance of fecal coliforms of weaned pigs subjected to experimental salmonella infection. Can J Comp Med (1973) 0.83

Transferable antibiotic resistance in E. coli and Klebsiella pneumoniae. Can Med Assoc J (1973) 0.77

Transferable antibiotic resistance. Br Med J (1968) 0.75

Infectious diseases. Annual review of significant publications. Postgrad Med J (1967) 0.75

Transferable drug resistance. Br Med J (1969) 0.75

Transferable Antibiotic Resistance on Tees-side. Br Med J (1968) 0.75

Transference of antibiotic resistance. Can Med Assoc J (1968) 0.75

Bacillary dysentery. Br Med J (1968) 0.75

Some historical aspects of bacterial resistance. Bull N Y Acad Med (1987) 0.75

Articles by these authors

(truncated to the top 100)

In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (1985) 12.08

Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol (1999) 11.77

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell (1987) 11.56

Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15

Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85

A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36

Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (1983) 5.90

Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68

Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J Clin Microbiol (1998) 5.27

Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94

Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80

R factors mediate resistance to mercury, nickel, and cobalt. Science (1967) 4.57

Expression of active human factor VIII from recombinant DNA clones. Nature (1984) 4.36

Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (1983) 4.06

Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1984) 3.98

Marburg-virus disease in Kenya. Lancet (1982) 3.79

A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74

Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33

Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31

Primary structure and biochemical properties of an M2 muscarinic receptor. Science (1987) 3.16

Mode of action of novobiocin in Escherichia coli. J Bacteriol (1967) 3.09

Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis. J Pediatr (1978) 3.05

The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol Appl Pharmacol (1969) 2.95

Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol (2000) 2.87

Do pili play a role in pathogenicity of Haemophilus influenzae type B? Lancet (1982) 2.84

Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81

Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74

Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66

Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48

Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45

The costs of treating COPD in the United States. Chest (2001) 2.43

Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42

Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci (1992) 2.41

Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J (1987) 2.39

Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b. J Pediatr (1972) 2.33

Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. Lancet (1975) 2.31

Studies on the epidemiology of resistance (R) factors. I. Analysis of Klebsiella isolates in a general hospital. II. A prospective study of R factor transfer in the host. Ann Intern Med (1969) 2.28

Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci (2001) 2.28

Recovery of resistance (R) factors from a drug-free community. Lancet (1969) 2.26

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A (1991) 2.24

Isolation and partial characterization of outer and inner membranes from encapsulated Haemophilus influenzae type b. J Bacteriol (1981) 2.21

The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics (1989) 2.17

The reliability of quantitative electroencephalography as an indicator of cerebral ischemia. Anesth Analg (1995) 2.12

The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess (2006) 2.04

Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2000) 2.03

The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01

A health week in rural general practice. Br Med J (1967) 1.99

Measuring appropriate use of acute beds. A systematic review of methods and results. Health Policy (2000) 1.97

An inhibitor of indoleacetic acid oxidase from pea tips. Plant Physiol (1961) 1.97

The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94

Who should practise? Where? CMAJ (1994) 1.87

Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b. Infect Immun (1982) 1.83

Resistance factor-mediated streptomycin resistance. J Bacteriol (1969) 1.78

The MHC-binding and gp120-binding functions of CD4 are separable. Science (1989) 1.77

Characterization of R factor beta-lactamases by the acidimetric method. Antimicrob Agents Chemother (1973) 1.76

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proc Natl Acad Sci U S A (1991) 1.76

Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis. J Clin Pathol (1982) 1.74

Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. Arch Intern Med (2000) 1.68

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet (1997) 1.67

R factor infection of Escherichia coli lyophilized in 1946. J Bacteriol (1967) 1.66

Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65

Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans R Soc Trop Med Hyg (1988) 1.65

Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer (1998) 1.61

Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following severe experimental brain injury in rats. Neuroscience (1998) 1.60

Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B. Clin Immunol Immunopathol (1973) 1.60

Biomechanical analysis of experimental diffuse axonal injury. J Neurotrauma (1995) 1.57

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet (1994) 1.50

The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines. JAMA (1996) 1.50

Vector expression of adenovirus type 5 E1a proteins: evidence for E1a autoregulation. Mol Cell Biol (1985) 1.49

Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation (1994) 1.46

Cloning and sequencing of the xylose isomerase and xylulose kinase genes of Escherichia coli. Appl Environ Microbiol (1984) 1.45

Genetic analysis of the folding pathway for the tail spike protein of phage P22. Proc Natl Acad Sci U S A (1983) 1.42

HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications. Int J Gynecol Cancer (2006) 1.41

Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules. J Immunol (1996) 1.40

Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b. Infect Immun (1977) 1.40

Pharmacokinetics of gentamicin in children and adults. J Infect Dis (1975) 1.39

The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol (1999) 1.39

Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant. J Immunol (1986) 1.38

Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab Invest (1996) 1.38

Fetal haemoglobin and malaria. Lancet (1976) 1.37

Mild experimental brain injury in the rat induces cognitive deficits associated with regional neuronal loss in the hippocampus. J Neurotrauma (1993) 1.37

Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat. J Neurosci (1996) 1.37

Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood (1991) 1.36

Lactoperoxidase and Iodo-Gen-catalyzed iodination labels inner and outer membrane proteins of Haemophilus influenzae. J Bacteriol (1983) 1.35

Comparison of the diagnostic methods of family physicians and internists. J Med Educ (1975) 1.35

Barriers to physician rankle. CMAJ (1995) 1.34

Catabolite repression of chloramphenicol acetyl transferase synthesis in E. coli K12. Biochem Biophys Res Commun (1971) 1.34

The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms. Neuropathol Appl Neurobiol (1998) 1.32

Comments on the ultrastructure of human erythrocytes infected with Plasmodium malariae. Ann Trop Med Parasitol (1970) 1.32

Nalbuphine. Drug Alcohol Depend (1985) 1.30

Serological studies with reovirus-like enteritis agent. Infect Immun (1976) 1.29

A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol (1997) 1.29

Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res (1996) 1.28

BIONET: national computer resource for molecular biology. Nucleic Acids Res (1986) 1.27

Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors. Blood (1994) 1.26

Temperature-sensitive mutants blocked in the folding or subunit assembly of the bacteriophage P22 tail-spike protein. I. Fine-structure mapping. Genetics (1980) 1.25

Prolonged activation of NF-kappaB following traumatic brain injury in rats. J Neurotrauma (1999) 1.25

Gentamicin in newborn infants. Comparison of intramuscular and intravenous administration. Am J Dis Child (1973) 1.24

Temperature-sensitive mutants blocked in the folding or subunit assembly of the bacteriophage P22 tail spike protein. III. Intensive polypeptide chains synthesized at 39 degrees C. J Mol Biol (1981) 1.24